Cargando…
Unraveling the mechanisms of IVIG immunotherapy in MIS-C
In The Journal of Clinical Investigation, Zhu et al.(1) report that intravenous immunoglobulin (IVIG) targets IL-1β(+) neutrophils to exert anti-inflammatory effects in multisystem inflammatory syndrome in children (MIS-C), a post-infectious inflammatory condition associated with COVID-19.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481087/ https://www.ncbi.nlm.nih.gov/pubmed/34608458 http://dx.doi.org/10.1016/j.xcrm.2021.100431 |